ANGO Angiodynamics Inc

Price (delayed)

$21.45

Market cap

$835.91M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.68

Enterprise value

$832.08M

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include ...

Highlights
Angiodynamics's EPS has increased by 33% from the previous quarter and by 17% YoY
ANGO's net income is up by 33% since the previous quarter and by 16% year-on-year
The quick ratio has decreased by 25% YoY and by 18% QoQ
The company's debt rose by 25% YoY

Key stats

What are the main financial stats of ANGO
Market
Shares outstanding
38.97M
Market cap
$835.91M
Enterprise value
$832.08M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.96
Price to sales (P/S)
2.65
EV/EBIT
N/A
EV/EBITDA
329.28
EV/Sales
2.63
Earnings
Revenue
$316.22M
EBIT
-$29.26M
EBITDA
$2.53M
Free cash flow
-$22.9M
Per share
EPS
-$0.68
Free cash flow per share
-$0.59
Book value per share
$10.95
Revenue per share
$8.11
TBVPS
$5.11
Balance sheet
Total assets
$552.75M
Total liabilities
$128.26M
Debt
$25M
Equity
$424.49M
Working capital
$69.02M
Liquidity
Debt to equity
0.06
Current ratio
1.93
Quick ratio
1.09
Net debt/EBITDA
-1.51
Margins
EBITDA margin
0.8%
Gross margin
52.4%
Net margin
-8.4%
Operating margin
-8.9%
Efficiency
Return on assets
-4.8%
Return on equity
-6.2%
Return on invested capital
-23.3%
Return on capital employed
-6.1%
Return on sales
-9.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ANGO stock price

How has the Angiodynamics stock price performed over time
Intraday
5.1%
1 week
8.01%
1 month
2.88%
1 year
-18.13%
YTD
-22.23%
QTD
4.84%

Financial performance

How have Angiodynamics's revenue and profit performed over time
Revenue
$316.22M
Gross profit
$165.73M
Operating income
-$28.05M
Net income
-$26.55M
Gross margin
52.4%
Net margin
-8.4%
The company's operating margin rose by 36% QoQ and by 26% YoY
The company's net margin rose by 35% QoQ and by 22% YoY
ANGO's operating income is up by 34% since the previous quarter and by 20% year-on-year
ANGO's net income is up by 33% since the previous quarter and by 16% year-on-year

Growth

What is Angiodynamics's growth rate over time

Valuation

What is Angiodynamics stock price valuation
P/E
N/A
P/B
1.96
P/S
2.65
EV/EBIT
N/A
EV/EBITDA
329.28
EV/Sales
2.63
Angiodynamics's EPS has increased by 33% from the previous quarter and by 17% YoY
The P/B is 40% more than the 5-year quarterly average of 1.4 but 11% less than the last 4 quarters average of 2.2
Angiodynamics's equity has decreased by 3.4% YoY
The P/S is 15% less than the last 4 quarters average of 3.1
The revenue has increased by 9% year-on-year and by 3.3% since the previous quarter

Efficiency

How efficient is Angiodynamics business performance
Angiodynamics's ROS has increased by 36% from the previous quarter and by 23% YoY
ANGO's ROIC is up by 36% QoQ and by 17% YoY
ANGO's ROA is up by 33% since the previous quarter and by 11% year-on-year
The ROE is up by 33% since the previous quarter and by 11% year-on-year

Dividends

What is ANGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANGO.

Financial health

How did Angiodynamics financials performed over time
ANGO's current ratio is down by 25% since the previous quarter and by 21% year-on-year
The quick ratio has decreased by 25% YoY and by 18% QoQ
The company's debt is 94% lower than its equity
The company's debt rose by 25% YoY
The debt to equity has grown by 20% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.